Targeting T cells for GVHD therapy

Research output: Contribution to journalReview articlepeer-review

5 Scopus citations


Bone marrow transplantation is currently used to treat a variety of life-threatening diseases. Its applications could be expanded if the risks of graft-versus-host disease (GVHD), a complex pathologic disease, could be reduced. Immunotoxins may provide a means to control drug refractory GVHD. This article will discuss the development of immunotoxin approaches for either GVHD prevention or treatment, and explore their limitations.

Original languageEnglish (US)
Pages (from-to)57-64
Number of pages8
JournalSeminars in Cancer Biology
Issue number2
StatePublished - Apr 1996


  • Bone marrow transplantation
  • Graft versus-host-disease
  • Immunotoxins
  • Mice
  • Therapy


Dive into the research topics of 'Targeting T cells for GVHD therapy'. Together they form a unique fingerprint.

Cite this